Namoc, Lolita U.
HRN: 03-17-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/19/2024
07/25/2024
IV
2.25gm
Q6
Cap Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes